ArticleCell research2022
K
Open access · hybridAbstract read
In one paragraph
Article in Cell research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 28 citations in OpenAlex.
- Evaluation of Novel Cloxyquin Analogs for KArchiv der Pharmazie · 2026Article
- Structure-Function Relationships of KAdvances in experimental medicine and biology · 2026Review
- Mesenchymal Stem Cells Modulate Regulatory T Cells: From Molecular Mechanisms to Disease Therapy.Stem cells international · 2026Review
- Calcium-dependent activation of TREK-1 and TREK-2 background potassium channels by calcineurin.Scientific reports · 2025Article
- Exercise facilitates post-stroke recovery through mitigation of neuronal hyperexcitability via interleukin-10 signaling.Nature communications · 2025Article
- The potassium channel KNature communications · 2025Article
- Bioinformatics analysis reveals shared molecular pathways for relationship between ulcerative colitis and primary sclerosing cholangitis.Genomics & informatics · 2025Article
- [(Auto)immunity in focal epilepsy: mechanisms of (auto‑)immune-inflammatory epileptogenic neurodegeneration].Der Nervenarzt · 2024Review
- The Ubiquitin Ligase Adaptor NDFIP1 Interacts with TRESK and Negatively Regulates the Background KInternational journal of molecular sciences · 2024Article
- Dynamic Changes in Ion Channels during Myocardial Infarction and Therapeutic Challenges.International journal of molecular sciences · 2024Review
- NF-κB in biology and targeted therapy: new insights and translational implications.Signal transduction and targeted therapy · 2024Review
- TLR4 induced TRPM2 mediated neuropathic pain.Frontiers in pharmacology · 2024Review
- Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations.Frontiers in immunology · 2024Review
- Cloxyquin activates hTRESK by allosteric modulation of the selectivity filter.Communications biology · 2023Article
- Thinking outside the box: non-canonical targets in multiple sclerosis.Nature reviews. Drug discovery · 2022Review
- Dietary regulation in health and disease.Signal transduction and targeted therapy · 2022Review
- The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.Journal of neurology · 2022Article
- The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis.Frontiers in immunology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
38 authors at 7 institutions in 2 countries.
Tobias Ruck *Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany. tobias.ruck@med.uni-duesseldorf.de.ORCID http://orcid.org/0000-0001-6332-8650
Stefanie Bock *Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
Steffen PfeufferDepartment of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Christina B SchroeterDepartment of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Derya CengizDepartment of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Paul MarciniakDepartment of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Maren LindnerDepartment of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
Alexander HerrmannDepartment of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Marie LiebmannDepartment of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
Stjepana KovacDepartment of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
Lukas GolaDepartment of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
Leoni RolfesDepartment of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Marc PawlitzkiDepartment of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
Nils OpelInstitute for Translational Psychiatry, University of Münster, Münster, Germany.
Tim HahnInstitute for Translational Psychiatry, University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0001-6541-3795
Udo DannlowskiInstitute for Translational Psychiatry, University of Münster, Münster, Germany.
Thomas PapInstitute of Experimental Musculoskeletal Medicine (IMM), University of Münster, Münster, Germany.
Felix LuessiDepartment of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Julian A SchreiberInstitute of Pharmaceutical and Medicinal Chemistry, University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0002-3847-7539
Bernhard WünschInstitute of Pharmaceutical and Medicinal Chemistry, University of Münster, Münster, Germany.
Tanja KuhlmannInstitute of Neuropathology, University of Münster, Münster, Germany.
Guiscard SeebohmCellular Electrophysiology and Molecular Biology, Institute for Genetics of Heart Diseases (IfGH), University of Münster, Münster, Germany.
Björn TackenbergDepartment of Neurology, Philipps-University, Marburg, Germany.
Patricia SejaLaboratory of Neurobiology, University of Helsinki, Helsinki, Finland.
Frank DöringMolecular Electrophysiology, Institute of Physiology and Center of Mental Health, University of Würzburg, Würzburg, Germany.
Erhard WischmeyerMolecular Electrophysiology, Institute of Physiology and Center of Mental Health, University of Würzburg, Würzburg, Germany.
Achmet Imam ChasanInstitute of Immunology, University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0001-5137-6890
Johannes RothInstitute of Immunology, University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0001-7035-8348
Luisa KlotzDepartment of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0001-5439-9633
Gerd Meyer Zu HörsteDepartment of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0002-4341-4719
Heinz WiendlDepartment of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.ORCID http://orcid.org/0000-0003-4310-3432
Tobias MarschallInstitute for Medical Biometry and Bioinformatics, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.ORCID http://orcid.org/0000-0002-9376-1030
Stefan FloessDepartment of Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Jochen HuehnDepartment of Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Thomas BuddeInstitute for Physiology I, University of Münster, Münster, Germany.
Tobias BoppInstitute of Immunology, Focus Program Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0002-3232-8065
Stefan BittnerDepartment of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Sven G MeuthDepartment of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
University of Münster · DEHeinrich Heine University Düsseldorf · DEJohannes Gutenberg University Mainz · DEHelmholtz Centre for Infection Research · DEUniversity of Würzburg · DEPhilipps University of Marburg · DEUniversity of Helsinki · FI
Funding
Deutsche Forschungsgemeinschaft (German Research Foundation) CRC-TR-128Deutsche Forschungsgemeinschaft (German Research Foundation) RTG 2515Deutsche Forschungsgemeinschaft (German Research Foundation) SFB BI1822/1-1
Abstract
It remains largely unclear how thymocytes translate relative differences in T cell receptor (TCR) signal strength into distinct developmental programs that drive the cell fate decisions towards conventional (Tconv) or regulatory T cells (Treg). Following TCR activation, intracellular calcium (Ca
Indexed as
Potassium ChannelsReceptors, Antigen, T-CellT-Lymphocytes, RegulatoryAnimalsCell DifferentiationForkhead Transcription FactorsHumansMiceNF-kappa BThymocytesThymus GlandForkhead Transcription FactorsNF-kappa BPotassium ChannelsReceptors, Antigen, T-Cell
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.